Institutional Ownership
Iovance Biotherapeutics Inc
CUSIP 462260100COMIOVAQ1 2026
Institutional Holders
276
13F filers
Shares Held
238.09M
Aggregate institutional
Institutional Value
$801.54M
Q1 2026
Net New Holders
+19
57 new · 38 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions57
Increased121
Decreased59
Sold out38
Institutional Holders
276 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 31.08M | $109.09M | +1.56M | Added |
| 2 | Mhr Fund Management LLC | 28.97M | $101.67M | 0 | Held |
| 3 | State Street Corp | 17.45M | $61.24M | −2.71M | Reduced |
| 4 | Two Sigma Investments, LP | 13.69M | $48.04M | +9.29M | Added |
| 5 | Millennium Management LLC | 9.41M | $33.04M | +2.83M | Added |
| 6 | Goldman Sachs Group Inc | 8.76M | $30.75M | +152.5K | Added |
| 7 | Geode Capital Management, LLC | 8.57M | $30.10M | +581.0K | Added |
| 8 | Invenomic Capital Management LP | 8.50M | $29.82M | −3.46M | Reduced |
| 9 | Bank Of America Corp /De/ | 8.49M | $29.80M | −5.79M | Reduced |
| 10 | D. E. Shaw & Co., Inc. | 8.02M | $28.14M | +4.19M | Added |
266 more institutional holders on Premium
See every fund holding Iovance Biotherapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders